Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» hyperkalemia
hyperkalemia
AstraZeneca calls off two late-stage potassium drug trials
Reuters
Fri, 12/1/23 - 09:34 am
AstraZeneca
clinical trials
Lokelma
hyperkalemia
AstraZeneca kicks off 2020 with double win in US and China
Pharmaforum
Mon, 01/6/20 - 10:23 am
AstraZeneca
FDA
Farxiga
heart failure
China
Lokelma
hyperkalemia
AstraZeneca potassium drug finally approved, threatening Vifor
Yahoo/Reuters
Mon, 05/21/18 - 09:01 am
AstraZeneca
Lokelma
hyperkalemia
ZS-9
Vifor
Valtessa
FDA
Ardelyx scraps late-stage drug in another pipeline setback
BioPharma Dive
Fri, 11/24/17 - 11:27 am
Ardelyx
RDX7675
hyperkalemia
FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
Fierce Pharma
Wed, 04/19/17 - 04:12 pm
FDA
AstraZeneca
ZS-9
ZS Pharma
hyperkalemia
FDA Rejects AstraZeneca’s Hyperkalemia Drug
Investopedia
Fri, 03/17/17 - 09:29 am
AstraZeneca
FDA
hyperkalemia
ZS-9
A Great Month For Relypsa
Seeking Alpha
Sat, 05/28/16 - 10:38 am
Relypsa
AstraZeneca
Veltassa
hyperkalemia
ZS-9
Biotechnology company Relypsa explores potential sale-sources
Yahoo/Reuters
Fri, 04/8/16 - 09:40 am
Relypsa
M&A
AstraZeneca
hyperkalemia
Relypsa's Veltassa Will Be Embraced By Physicians
Seeking Alpha
Thu, 10/22/15 - 07:25 pm
Relypsa
Veltassa
physicians
hyperkalemia
Relypsa, Sanofi marketing teams revved up and waiting for FDA nod on patiromer
Fierce Pharma Marketing
Wed, 10/21/15 - 09:13 pm
Sanofi
Relypsa
patiromer
hyperkalemia
Sanofi adds its sales heft to Relypsa's forthcoming patiromer launch
Fierce Pharma Marketing
Sat, 08/15/15 - 10:52 am
Sanofi
Relypsa
drug launches
drug reps
hyperkalemia
patiromer
Encouraging Results For Two New Drugs That Fight A Common And Dangerous Side Effect
Forbes
Fri, 11/21/14 - 03:10 pm
RAAS
ZS Pharma
hyperkalemia
ZS-9
Relypsa
ZS Pharma begins enrollment in phase 3 study of ZS-9 in Hyperkalemia patients
Pharmabiz
Sat, 06/28/14 - 11:49 am
hyperkalemia
ZS Pharma
ZS-9